STONEPINE CAPITAL MANAGEMENT, LLC – Ligand Pharmaceuticals Incorporated Transaction History
STONEPINE CAPITAL MANAGEMENT, LLC portfolio value:
$8.57M
portfolio value
STONEPINE CAPITAL MANAGEMENT, LLC quarter portfolio value change:
-3.49%
quarter
Ligand Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.68% | -682 shares | -371K | $86.11 | 99.56K |
| Q2 2022 | share | Increase | +36.02% | 26.54K shares | 653K | $89.22 | 100.24K |
| Q1 2022 | share | Increase | 0.00% | 73.7K shares | 8.29M | $112.49 | 73.7K |
| Q1 2021 | share | Decrease | -100.00% | -326.1K shares | -32.43M | $152.45 | 0 |
| Q4 2020 | share | Increase | +1.43% | 4.6K shares | 1.78M | $99.45 | 326.1K |
| Q3 2020 | share | Increase | +247.92% | 229.09K shares | 20.30M | $95.32 | 321.5K |
| Q2 2020 | share | Decrease | -42.58% | -68.51K shares | -1.36M | $111.85 | 92.40K |
| Q1 2020 | share | Increase | 0.00% | 160.91K shares | 11.70M | $72.72 | 160.91K |
| Q4 2019 | share | Decrease | -100.00% | -29.96K shares | -2.98M | $104.29 | 0 |
| Q3 2019 | share | Decrease | -82.11% | -137.52K shares | -16.13M | $99.54 | 29.96K |
| Q2 2019 | share | Increase | +11.66% | 17.48K shares | 262K | $114.15 | 167.48K |
| Q1 2019 | share | Increase | 0.00% | 150K shares | 18.85M | $125.71 | 150K |